Mankind Pharma Limited IPO

Mankind IPO

[{"selector":"#anim-59209ad7-67da-4f6c-aa5f-0bdb5670d8d3","keyframes":{"opacity":[0,1]},"delay":100,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ced98310-9e84-44ee-8a28-dc3db819a269","keyframes":{"transform":["translate3d(-117.0418%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":100,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-58bb8657-f389-49fd-9947-015accc82cb3","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-5ef6ec29-ab4a-490d-925c-5e43a6c97386","keyframes":{"opacity":[0,1]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-352bde99-d827-4f26-ac81-7a2928ea8789","keyframes":{"transform":["translate3d(-115.75562%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-3168055a-a01a-42f7-b4b9-afd78fde12a7","keyframes":{"opacity":[0,1]},"delay":300,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e173c05b-7f52-4fe4-a015-d0f83d7b969c","keyframes":{"transform":["translate3d(-116.07717%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":300,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-9159d49c-da34-440b-96f2-7eb0d3f22947","keyframes":{"opacity":[0,1]},"delay":400,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-03d03ed6-3246-43a9-8d8e-1a454724956e","keyframes":{"transform":["translate3d(-116.72026%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":400,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a1032e3c-c48a-4062-a5c8-e2e2d8b30e0d","keyframes":{"opacity":[0,1]},"delay":500,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-7df35e8d-7cab-442e-8d69-419a11186951","keyframes":{"transform":["translate3d(-116.72026%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":500,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] 1. Mankind Pharma Limited is a pharmaceutical company that develops, produces, and distributes pharmaceutical formulations and consumer healthcare products since 1991 . 2. Mankind Pharma Limited focuses on a range of acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular diseases, gastrointestinal issues, and respiratory ailments . 3. Mankind Pharma Limited offers over 36 brands that are popularly used in India, including Manforce, Moxikind-CV, and Prega News, among others . 4. Mankind Pharma has a vast distribution network of medical reps in India, and 80% of Indian doctors prescribe their formulations , making them the fourth in domestic sales during the Financial Year 2022. 5. Mankind Pharma Limited operates 23 manufacturing facilities in India with diverse dosage forms, including tablets, capsules, syrups, and more.

Competitive Strength

[{"selector":"#anim-ffe2aba3-1db4-4de4-9634-938c7b1f7b81","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-5a6b9054-15d0-49dd-86b3-6396e2681de0","keyframes":{"opacity":[0,1]},"delay":100,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-41074e08-4cde-4a0d-afa0-a014b90fd8a0","keyframes":{"transform":["translate3d(-114.69649%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":100,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8e2411d1-f3ff-4642-90f6-4c22c436a042","keyframes":{"opacity":[0,1]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-84e55095-1ab3-4dc4-9222-45d1841aff39","keyframes":{"transform":["translate3d(-115.33547%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f118b372-ae02-45ad-acff-05d95dd04c8e","keyframes":{"opacity":[0,1]},"delay":300,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8d981ab9-30c9-4b95-bb3e-ef47f7546c2f","keyframes":{"transform":["translate3d(-117.49175%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":300,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-4d759501-6161-4408-bd1b-e6061b761596","keyframes":{"opacity":[0,1]},"delay":400,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-928f234c-94ff-4048-a20d-664e48fea043","keyframes":{"transform":["translate3d(-115.43409%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":400,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ac994bb9-c584-4df4-808e-cf8753ad767c","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}]

Objective

[{"selector":"#anim-7c78bdfd-9219-4479-8979-50bb07a67fd5","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d0f03c82-1fe4-4b53-a8ea-353b544c08fc","keyframes":{"opacity":[0,1]},"delay":100,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-33c418d9-e0c2-4e77-bc7c-26112273c459","keyframes":{"transform":["translate3d(-110.61946%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":100,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d193c038-05ac-48dd-b97f-53350a5b47f7","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}]

Basic Details

[{"selector":"#anim-c99b4478-2646-41f1-a477-0f4dc1161cbc","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-7aa6270c-ae81-46b7-9ee4-eb779ff2b224","keyframes":{"opacity":[0,1]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-5a4ed153-324f-4cd6-8915-8f0458ae37c7","keyframes":{"transform":["translate3d(-112.34568%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-3a2bb58f-bdc0-4c3a-8b49-f5fb085f8235","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] IPO Date: Apr 25, 2023 to Apr 27, 2023 Price: ₹1026 to ₹1080 per share Lot Size: 13 Shares Issue Size: ₹4,326 Cr OFS Issue: ₹4,326 Cr Issue Type: Book Built Issue IPO Listing At: NSE BSE

Timetable

[{"selector":"#anim-5a36f1d3-0f6f-4783-b0e0-8775cd9fd99c","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-3b85306a-816c-419b-81ad-d67533b8e073","keyframes":{"opacity":[0,1]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-73ad9a2b-44e7-4e54-9114-a39e7027e99f","keyframes":{"transform":["translate3d(-107.88733%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f105e2fe-2f73-434c-ac24-c5af6d3951cd","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Opening Date: Apr 25, 2023 Closing Date: Apr 27, 2023 Basis of Allotment: May 3, 2023 Initiation of Refunds: May 4, 2023 Credit of Shares to Demat: May 5, 2023 Listing Date: May 8, 2023 10.00 A.M. to 5.00 p.m. Upto which mandate can be applied

Lot Size

[{"selector":"#anim-7b5995a7-eab0-4187-b810-675d862cbb31","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-9cbca60f-8f3b-448c-a278-5f3789c1afb4","keyframes":{"opacity":[0,1]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-48834cfb-b3a0-4f3b-bd6e-4e3241908dfa","keyframes":{"transform":["translate3d(-105.94595%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e9a8e585-a8d2-4282-9a69-1bb3a72e3151","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Application Lots Shares Amount Retail (Min): 1 13 ₹14,040 Retail (Max): 14 182 ₹196,560 S-HNI (Min): 15 195 ₹210,600 S-HNI (Max): 71 923 ₹996,840 B-HNI (Min): 72 936 ₹1,010,880

Promoter Holding

[{"selector":"#anim-e6228c55-1695-47a6-93ad-a0307a101024","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-62cc493c-4d9d-4fdd-896c-371c8c1b7cbd","keyframes":{"opacity":[0,1]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c4d827f9-54e1-4ed7-8800-4b5c7e55b251","keyframes":{"transform":["translate3d(-113.45566%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-938b8aa0-4c21-494f-aec7-29b5196bdda1","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-5e386f76-94da-4ac7-bb2b-7ba2a8ebd5a5","keyframes":{"opacity":[0,1]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8594ef6f-d378-4423-9ce6-6130c86512f2","keyframes":{"transform":["translate3d(-113.62229%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b261b098-8edc-48e8-a1c4-01d00c20af75","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Pre Issue Share Holding: 79.00% Post Issue Share Holding: No Data Earning Per Share (EPS): ₹35.78 P/E Ratio: No Data Return on Net Worth (RoNW): 23.29% Net Asset Value (NAV): ₹153.65 per Equity Share Price/BV Ratio: No Data

Key Performance Indicator

[{"selector":"#anim-417d5672-2ba3-47f0-beb2-a0d38bfe7646","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-fada699f-47b3-4889-a50d-4257486044e4","keyframes":{"opacity":[0,1]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-afb9a926-38ed-4310-b935-734ab7f48b1c","keyframes":{"transform":["translate3d(-115.11254%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-6ba2698b-bada-450a-8f46-e1cf5cfe5be2","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Market Cap (₹ Cr.): 43263.55 P/E Ratio: No Data Return on Equity (ROE) (%): 25.99 Return on Capital Employed (ROCE) (%): 25.50 EBITDA Margin (%): 25.75 Debt/Equity: 0.02

Peer Comparison

[{"selector":"#anim-4ce4ac83-5e1b-4431-a2df-5c65af0fd2e8","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-017a65f9-a0da-4c28-be4c-401a558fe445","keyframes":{"opacity":[0,1]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-9d9c7682-fc3a-4bf6-be04-57a6853913fd","keyframes":{"transform":["translate3d(-116.39871%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e664bbd8-fd20-45c2-b3e3-595457fe4e38","keyframes":{"opacity":[0,1]},"delay":250,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-bc826824-fa72-44c0-b41b-11c8ae923977","keyframes":{"transform":["translate3d(-114.8265%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":250,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f3eb63d9-049e-4e01-955a-16a5775efb0b","keyframes":{"opacity":[0,1]},"delay":300,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-9a5aff6e-f8f1-4ba2-88c4-b087fe5a8441","keyframes":{"transform":["translate3d(-113.88012%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":300,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-3f7065aa-71a8-4732-8a62-3af54aed41e2","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-9a9c17a4-b09b-4a02-9d2b-52bddc5503dd","keyframes":{"opacity":[0,1]},"delay":350,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-30f53e90-0410-4c24-a1e8-668e7d8e005a","keyframes":{"transform":["translate3d(-113.16614%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":350,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c9775694-39c9-46b3-a898-c3b71f99270e","keyframes":{"opacity":[0,1]},"delay":400,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-47929d4a-5115-46e4-b1d0-b658fa8c18ae","keyframes":{"transform":["translate3d(-112.93376%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":400,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e030deec-aa13-4e68-9a0e-60d057d4cd65","keyframes":{"opacity":[0,1]},"delay":450,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d18fc12b-8461-4b38-85ee-14f57328754f","keyframes":{"transform":["translate3d(-114.19558%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":450,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e718b513-21c0-43cf-83a5-fcf12c1b0e10","keyframes":{"opacity":[0,1]},"delay":500,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-90b49393-b74a-4a8b-b6be-d9da72e2cf10","keyframes":{"transform":["translate3d(-114.10658%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":500,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}]

Our Rating

[{"selector":"#anim-7ded878a-0ad7-452c-8004-85f897612617","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d429a230-e998-40c2-97c0-b58d294b170f","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-90360b36-7e5c-4dfd-bd44-292a61fda330","keyframes":{"transform":["scale(1)","scale(1.5)","scale(0.95)","scale(1)"],"offset":[0,0.33,0.66,1]},"delay":200,"duration":1450,"easing":"ease-in-out","fill":"both","iterations":1}] [{"selector":"#anim-e019a3a1-2a76-4008-a60a-710ed19e2e0d","keyframes":{"opacity":[0,1]},"delay":100,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-bbe20407-ca27-4327-b07e-2ff6b002214c","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-54380751-43da-430e-a6a9-04b4a4ff202a","keyframes":{"transform":["scale(1)","scale(1.5)","scale(0.95)","scale(1)"],"offset":[0,0.33,0.66,1]},"delay":300,"duration":1450,"easing":"ease-in-out","fill":"both","iterations":1}] [{"selector":"#anim-5d6681c4-ff01-4fbd-9950-85fbab4350d8","keyframes":{"transform":["scale(1)","scale(1.5)","scale(0.95)","scale(1)"],"offset":[0,0.33,0.66,1]},"delay":400,"duration":1450,"easing":"ease-in-out","fill":"both","iterations":1}]

More Update

[{"selector":"#anim-c436a157-1358-4ebd-b750-96a22082415b","keyframes":[{"offset":0,"transform":"translate3d(0, -494.94937%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":0.29,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"},{"offset":0.45,"transform":"translate3d(0, -139.179762844%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":0.61,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"},{"offset":0.71,"transform":"translate3d(0, -47.317159772000004%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":0.8,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"},{"offset":0.85,"transform":"translate3d(0, -17.768682383%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":0.92,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"},{"offset":0.96,"transform":"translate3d(0, -7.721210171999999%, 0)","easing":"cubic-bezier(.5, 0, 1, 1)"},{"offset":1,"transform":"translate3d(0, 0%, 0)","easing":"cubic-bezier(0, 0, .5, 1)"}],"delay":0,"duration":600,"fill":"both"}] [{"selector":"#anim-5cda6396-fc68-45c7-8be6-31b7b70f5d22","keyframes":{"opacity":[0,1]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-dcd45066-8269-408b-80d0-2ff33553c3af","keyframes":{"transform":["rotate(-360deg) translate3d(-188.67925%, 0px, 0) rotate(360deg)","rotate(-360deg) translate3d(0px, 0px, 0) rotate(360deg)"]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-decba585-8110-4fb1-bb2f-0fecbd6b13bb","keyframes":{"opacity":[0,1]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f818909e-f6cd-4563-b77f-e877d0b8f62e","keyframes":{"transform":["translate3d(118.25096%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":200,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-5563fbb3-0bf5-4fbb-978d-5b5399e9cf33","keyframes":{"opacity":[0,1]},"delay":300,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-6e87a085-f5dc-48b2-9ab2-b8836aab7aab","keyframes":{"transform":["translate3d(120.86613%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":300,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-5d060c00-7643-4f84-8e1c-bc091a70e64d","keyframes":{"opacity":[0,1]},"delay":300,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-6ba5a2fc-7c1d-4d10-bee2-32442de3f41f","keyframes":{"transform":["rotate(-360deg) translate3d(-188.67925%, 0px, 0) rotate(360deg)","rotate(-360deg) translate3d(0px, 0px, 0) rotate(360deg)"]},"delay":300,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-9eeea0a9-1dee-4c8b-89b9-303cda920db4","keyframes":{"opacity":[0,1]},"delay":500,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-cffc63d9-1a1e-4087-b1c8-7213488a8b14","keyframes":{"transform":["translate3d(119.54025%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":500,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b236d170-f0bc-45e4-bab3-6b984f5aac95","keyframes":{"opacity":[0,1]},"delay":600,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-39c3c324-5443-4405-8d1c-18e752d01b00","keyframes":{"transform":["translate3d(120.47242%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":600,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d1670720-6fa6-4f1e-9d5a-826a5d5a1ac6","keyframes":{"opacity":[0,1]},"delay":500,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-eb81c887-079e-418c-9f0a-4bbe496364f9","keyframes":{"transform":["rotate(-360deg) translate3d(-188.67925%, 0px, 0) rotate(360deg)","rotate(-360deg) translate3d(0px, 0px, 0) rotate(360deg)"]},"delay":500,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-65c3ffe6-d747-47ac-8dad-6e625efcb119","keyframes":{"opacity":[0,1]},"delay":600,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d473ecb0-c085-4471-8ade-7238d6551a0b","keyframes":{"transform":["rotate(-360deg) translate3d(-188.67925%, 0px, 0) rotate(360deg)","rotate(-360deg) translate3d(0px, 0px, 0) rotate(360deg)"]},"delay":600,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e5bd4168-4dc2-4f81-8296-20919991d05f","keyframes":{"opacity":[0,1]},"delay":400,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e8ae359d-27d1-49c2-923f-803f4d33aea1","keyframes":{"transform":["translate3d(115.63637%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":400,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-20e56bb3-aa56-43d5-be8a-6903c9ee165e","keyframes":{"opacity":[0,1]},"delay":400,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d60b1ea6-2a96-41c4-bb20-2b7c1506d7b7","keyframes":{"transform":["rotate(-360deg) translate3d(-188.67925%, 0px, 0) rotate(360deg)","rotate(-360deg) translate3d(0px, 0px, 0) rotate(360deg)"]},"delay":400,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Learn more

Mankind Pharma Limited IPO

Mankind Pharma Limited IPO

DATE | SIZE | PRICE | DETAILS | REVIEW | GMP | LISTING GAIN | ALLOTMENT

Mankind IPO

Mankind IPO

Competitive Strength

Competitive Strength

1. Scaled domestic focused business with potential for further growth

2. Growing faster than the rate of the IPM with a focus on volume-led growth

3. Established and growing consumer healthcare franchise with brand recall

4. Experienced and professional management team backed by private equity investors

Mankind IPO

Mankind IPO

Objective

Objective

When shares are sold, the selling shareholders will receive all of the offer proceeds. The amount they receive is proportional to the number of shares they sold. The company itself will not receive any of the proceeds.

Mankind IPO

Mankind IPO

Basic Details

Basic Details

Mankind IPO

Mankind IPO

Timetable

Timetable

Mankind IPO

Mankind IPO

Lot Size

Lot Size

Mankind IPO

Mankind IPO

Promoter Holding

Promoter Holding

Promoter Valuation

Promoter Valuation

Mankind IPO

Mankind IPO

Key Performance Indicator

Key Performance Indicator

Mankind IPO

Mankind IPO

Peer Comparison

Peer Comparison

Sun Pharmaceuticals Industries Limited

Cipla Limited

Zydus Lifesciences Limited

Mankind IPO

Mankind IPO

Torrent Pharmaceutical Limited

Abbott India Limited

Alkem Laboratories

JB Chemicals & Pharmaceuticals Limited

Our Rating

Our Rating

3.0/5.0

For More Details

For More Details

Click Here

Mankind IPO

Mankind IPO

More Update

More Update

Check Live GMP

Check Live GMP

Upcoming IPO List

Upcoming IPO List

Business News

Business News

Check Our Website

Check Our Website

Latest IPO News

Latest IPO News